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Abstract 
Dysregulation of genetic pathways during human germ cell development leads to infertility. 
Here, we analyzed bona fide human primordial germ cells (hPGCs) to probe the developmental 
genetics of human germ cell specification and differentiation. We examined distribution of OCT4 
occupancy in hPGCs relative to human embryonic stem cells (hESCs).  We demonstrate that 
development, from pluripotent stem cells to germ cells, is driven by switching partners with 
OCT4 from SOX2 to PAX5 and PRDM1. Gain- and loss-of-function studies revealed that PAX5 
encodes a critical regulator of hPGC development. Moreover, analysis of epistasis indicates that 
PAX5 acts upstream of OCT4 and PRDM1.  The PAX5-OCT4-PRDM1 proteins form a core 
transcriptional network that activates germline and represses somatic programs during human 
germ cell differentiation.  These findings illustrate the power of combined genome editing, cell 
differentiation and engraftment for probing human developmental genetics that have historically 
been difficult to study.   
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Introduction 
Substantial research has centered on identification and characterization of genes that are 
required for specification, maintenance and differentiation of the mammalian primordial germ 
cells (PGCs) that ultimately give rise to the sperm and eggs required to perpetuate life1-13. In 
mice, several transcription factors have been identified that are required for in vitro specification 
and induction of the earliest stages of germ cells; these germ cells are ultimately able to mature 
and fulfill the greatest test of germ cell identity, the ability to produce live offspring10,14-18. 
However, the transcriptional network of human primordial germ cells (hPGCs) differs 
substantially from that of mice, making it difficult to translate knowledge directly to humans11. 
For example, hPGCs express lineage specifier genes that are not expressed in mouse PGCs, 
including SOX1719.   
 
Although hPGCs are committed to the germ cell lineage, they share expression profiles of 
several pluripotency genes with human embryonic stem cells (hESCs), including OCT4 (also 
known as POU5F1); however, other key pluripotency genes, such as SOX2, are not expressed 
in hPGCs11,20,21. How the network of pluripotency genes, that encodes transcription factors, 
functions differently in hESCs and hPGCs, is a fundamental question in the field of human germ 
cell developmental genetics that has remained unaddressed.  Thus, in this study, we elucidated 
genetic mechanisms that underlie development of hPGCs by identifying transcription factors 
that might function in a network to mediate hPGC specification and differentiation. We focused 
on OCT4, an essential gene that encodes a transcription factor that is expressed in both hESCs 
and hPGCs where it is required to maintain cell identity in both cell types22-24. We developed 
methods to map the genome-wide binding of OCT4 protein in highly heterogeneous tissue 
samples and identified OCT4 protein partners in hPGCs. We then used gain- and loss-of-
function gene analyses to probe the function of PAX5, a member of the paired box (PAX) family, 
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and discovered that it encodes a critical component of a genetic switch that is required for the 
transition from pluripotent stem cells to differentiation of hPGCs.   
 
Results 
Global redistribution of OCT4 occupancy in the transition from hPSCs to hPGCs 
To probe the role of OCT4 in hPGCs, we performed OCT4 Chromatin Immunoprecipitation 
Sequencing (ChIP-seq) analysis on germ cells from second trimester human fetal testis, a 
developmental stage when hPGCs have colonized the testis and are in the process of 
expanding to approximately 1-2M total cells, but have not differentiated to spermatogonia or 
spermatocytes6. We note that OCT4-positive cells are only present in the seminiferous tubules 
of the testis and not within the interstitial spaces (Fig. 1a, Supplementary Fig. 1a).  
Immunostaining data also indicated that OCT4-positive cells are a subpopulation of cKIT-
positive cells and do not express the DDX4 gene, which is an evolutionarily-conserved germ cell 
marker of later stages of development (post-PGC; Supplementary Fig. 1b, c).  However, since 
only 1% of the cells in the human fetal testis are OCT4-positive hPGCs (Fig.1a, Supplementary 
Fig. 1a), and conventional ChIP protocols require a large number of homogenous cells, we 
adapted protocols from carrier ChIP25 and tissue ChIP26 to detect binding specificity of individual 
transcription factors within a heterogeneous cell mixture. We validated our protocol using a 
heterogeneous control mixture of 10,000 OCT4-positive hESCs mixed with 990,000 OCT4-
negative fibroblast cells to model composition of fetal testis (Supplementary Fig.1d). We 
compared these data to that generated by conventional ChIP on a pure population of 1 million 
hESCs by quantitative PCR (Supplementary Fig.1e) and ChIP-seq and found the result from 
mixed-ChIP highly correlates that from conventional ChIP (Supplementary Fig.1f-h). Thus, our 
methods are reliable for generation of binding data from a heterogeneous mixture of cells when 
coupled with highly-specific antibodies. 
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We then applied the mixed-ChIP protocol to human fetal testis and generated a global binding 
profile for OCT4 in bona fide hPGCs. Two biological replicates were used and demonstrated 
gene overlap >90% (Supplementary Fig. 1h). Although the enrichment profile of OCT4 around 
the transcription start sites (TSS) was similar in both hPGCs and hESCs (Fig. 1b), there was a 
substantial redistribution of OCT4 binding, characterized by reduced binding near pluripotency-
related genes (e.g. OCT4, NANOG, LIN28A) and an enrichment of binding near germ cell-
related genes (e.g. PIWIL1, DDX4, NANOS2) in hPGCs relative to hESCs (Fig. 1c, d). 
Furthermore, Gene Ontology (GO) analysis of genes bound by OCT4 only in hPGCs revealed 
that genes were enriched in GO terms that include male gamete generation and 
spermatogenesis, while genes bound by OCT4 in both hESCs and hPGCs were enriched in 
neuronal development, potentially suggesting that OCT4 may repress ectoderm differentiation in 
both cell types (Fig. 1e). Together, our data demonstrated that the cell fate change from 
pluripotent hESCs to bona fide germline hPGCs is associated with global reorganization of 
OCT4 occupancy.  
 
OCT4 switches partners to PAX5 and PRDM1 in hPGCs  
We next set out to determine whether the genomic redistribution of OCT4 could be due to 
alternative OCT4 binding partners in hPGCs relative to hESCs. Immunostaining and RNA 
expression data showed that the expression of the SOX2, OTX2 and ZIC2, genes which encode 
well-characterized functional partners of OCT4 in hESCs27,28 29 30, are significantly 
downregulated in hPGCs (Supplementary Fig. 2a, b)31. This indicated that OCT4 might require 
different partners in hPGCs than in hESCs. To screen for potential OCT4-interacting 
transcription factors in hPGCs, we performed de novo sequence motif searches using OCT4-
bound sequences exclusively in hPGCs and discovered motifs that are similar to consensus 
motifs for the transcription factors PAX5 (Paired Box Homeotic Gene 5) and PRDM1 (Positive 
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Regulatory Domain I-Binding Factor 1) (Fig. 2a). Immunostaining demonstrated extensive co-
expression of PAX5 and PRDM1 in OCT4-positive cells (Fig. 2b). Quantitation indicates that 
approximately 60% of the OCT4 +cells are also positive for PAX5 and PRDM1. RNA expression 
analysis also showed significant induction of PAX5 and PRDM1 in hPGCs compared to hESCs 
(Supplementary Fig. 2b)31. This suggested that PAX5 and PRDM1 might co-occupy genomic 
loci with OCT4 as functional complexes in a germ cell specific transcriptional network. 
 
To determine the binding profiles of PAX5 and PRDM1 and probe potential association with 
OCT4 in hPGCs, we performed ChIP-seq analysis for both PAX5 and PRDM1 (Supplementary 
Fig. 2c). Among the top 5000 genes bound by each transcription factor, 1441 genes, including 
germ cell specific genes (eg., DDX4, DAZL and PIWIL1), were collectively bound by all three 
transcription factors (Fig. 2c, d).  These results suggested extensive co-occupancy of PAX5, 
PRDM1 and OCT4 in hPGCs. Annotation analysis revealed that these co-bound genes are 
enriched for GO terms of germ cell signaling, hESC pluripotency and bone morphogenetic 
proteins (BMP) signaling pathways (Fig. 2e). In addition, we observed that recombinant OCT4-
GST fusion protein can immunoprecipitate recombinant PAX5 protein in vitro (Fig. 2f), indicating 
that PAX5 may interact directly with OCT4 protein in hPGCs. We did not detect direct protein 
interactions between recombinant OCT4 and PRDM1 proteins. However, PRDM1 protein was 
pulled down by PAX5 and vice versa (Supplementary Fig. 2d), indicating that OCT4, PAX5 and 
PRDM1 may assemble as a protein complex through both direct and indirect interactions. In 
summary, our observations suggested that OCT4, partnering with PAX5 and PRDM1 proteins, 
might constitute an extensive and unique transcription network in hPGCs. 
 
Overexpression of PAX5 and PRDM1 induces human germ cell differentiation 
Although PRDM1 is a well-studied, key regulator of PGC development in both mouse and 
human15,19,32, the discovery of PRDM1 as a binding partner of OCT4 has never been shown. 
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Additionally, although PAX5 is most commonly known for its role in development of the blood 
system33, a potential role for PAX5 in PGC development or specification has not been reported. 
To investigate the roles of both genes in hPGCs, we examined whether overexpression (OE) of 
PAX5 and PRDM1 is capable of directing hESCs to the germ cell lineage in an in vitro 
differentiation system. We overexpressed PAX5 or PRDM1 by approximately 10-15 times above 
the endogenous expression levels (Supplementary Fig. 3a), to a level comparable to that of 
bona fide hPGCs (Supplementary Fig. 2b). Forced expression of either PAX5 or PRDM1 does 
not alter the identity of ESCs in routine hESC maintenance (Supplementary Fig. 3b, c). Next, we 
differentiated PAX5 OE and PRDM1 OE hESCs by subjecting the cells to BMPs for 7 days as 
previously described5,34. The expression of germ cell marker genes, including DAZL, DDX4, 
DPPA3 and NANOS3, is upregulated significantly in OE cells compared with non-OE control 
cells (Fig. 3a, Supplementary Fig. 3d). PAX5 also demonstrated binding on several later stage 
germ cells genes and activated their expression during differentiation, such as SYCP1 and 
SYCP3 (Fig. 3a, Supplementary Fig. 3e). Interestingly, co-expression of PAX5 and PRDM1 
showed no obvious additive effects relative to single factor OE (Supplementary Fig. 3f). 
Immunostaining reveals DDX4 signal in PAX5 OE cells, but not control cells (Fig. 3b). We also 
used a hESC-DDX4-mOrange knock-in reporter cell line to better characterize the effects of in 
vitro differentiation. We observed a significantly higher percentage of DDX4-mOrange+ cells in 
the PAX5 OE cells by FACS (fluorescence-activated cell sorting) relative to control cells (Fig. 
3c). These data demonstrated that induced expression of PAX5 and PRDM1 in hESCs strongly 
promotes differentiation of germ cells in vitro and prompted us to explore whether these cells 
may further mature if placed in the somatic niche via xenotransplantation. 
 
To investigate differentiation potential in vivo, we used a previously-developed 
xenotransplantation platform2-4. Briefly, we transplanted GFP-tagged human cells into busulfan-
treated immunodeficient mice, which are depleted of endogenous germ cells (Fig. 3d, 
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Supplementary Fig. 4a). Two months post-transplantation, we analyzed the testes and observed 
significant human germ cell engraftment in the tubules for OE cells, as indicated by the 
presence of GFP+ cells that co-expressed DDX4 (Fig. 3e). More importantly, PAX5 OE cells 
differentiated to a later stage germ cell fate that expressed mature germ cell markers, such as 
DAZL and DAZ1 (Fig. 3f). To quantify germ cell potential, we counted GFP+/DDX4+ human 
germ cells and tubules across entire cross-sections. We then calculated the percentage of 
positive tubules and determined the number of GFP+/DDX4+ cells in each positively stained 
tubule. Both values were significantly higher in PAX5 OE and PRDM1 OE cells (Fig. 3g, h). 
Consistent with in vitro differentiation results, PAX5 OE and PRDM1 OE promoted germ cell 
differentiation of hESCs in the mouse seminiferous tubule; however, no additive effects have 
been detected compared to single OE cells (Supplementary Fig. 4b-d). These data provide 
strong evidence that overexpression of PAX5 and PRDM1 is able to greatly promote 
differentiation potential of hESCs towards germ cell lineage in vitro and in vivo.  
 
Knockout of PAX5 or PRDM1 reduces germ cell potential of hESCs 
We further examined the role of PAX5 in germ cell differentiation by loss-of-function studies. We 
generated a PAX5 knockout (KO) hESC line via use of CRISPR/Cas9-based genome editing 
(Supplementary Fig. 5a, b). PAX5 KO was confirmed by immunofluorescence and Western blot 
analysis upon induced neuronal differentiation (Supplementary Fig. S5c, d)35,36. Moreover, a 
significant reduction of germ cell gene expression was observed after in vitro differentiation (Fig. 
4a) and DDX4 was not detected (Fig. 4b) further indicating a severe reduction of germ cell 
differentiation in vitro. We then examined whether germ cells could be differentiated and 
maintained from these cell lines via in vivo xenotransplantation. As noted, PAX5 KO cells gave 
rise to significantly fewer positive tubules with human germ cells and fewer GFP+/DDX4+ cells 
in the positive tubules; most of the DDX4+ cells were mouse germ cells regenerated after 
treatment (Fig. 4c). There was a >3-fold reduction of positive tubules and >5-fold reduction of 
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GFP+/DDX4+ cells in the positive tubules (Fig. 4d, e) indicating that genetic knockout of PAX5 
greatly reduced germ cell differentiation from hESCs. 
 
Previous studies revealed that PRDM1-knockout hESCs fail to develop into PGCs in vitro19. To 
determine if these cells were also compromised in terms of germ cell differentiation in vivo, we 
used previously-reported PRDM1 KO hESCs19 to test ability to differentiate to germ cells in 
murine xenotransplants. We observed that PRDM1 KO hESCs were severely deficient in germ 
cell differentiation in vivo (Fig. 4f) with the majority of tubules devoid of any human germ cell 
engraftment. Only a small number of tubules were observed with sparse GFP+/DDX4+ cells. 
Counts of the engraftment revealed a >10-fold reduction in formation of human germ cells in the 
mouse tubules (Fig. 4g, h), resulting in a more severe defect in germ cell potential compared to 
PAX5 KO cells.  
 
Epistasis of PAX5, OCT4 and PRDM1 in hPGCs: PAX5 acts upstream of OCT4 and 
PRDM1 
To explore the molecular mechanism of PAX5 function in hPGCs, we re-analyzed our ChIP-seq 
data and observed that the enhancers of OCT4, which are bound by OCT4 itself in hESCs, are 
bound by PAX5 in hPGCs (Fig. 5a). Thus, we hypothesized that one role of PAX5 is to regulate 
and maintain OCT4 expression, as germ cell differentiation proceeds and requires expression of 
OCT4 at moderate levels37. We tested this hypothesis, first, by examining OCT4 expression 
during in vitro differentiation. Following BMP-induced differentiation, OCT4 expression in PAX5 
OE cells was substantially elevated relative to differentiated controls (Fig. 5b). However, due to 
the developmental limitation of current in vitro differentiation, genes essential for later stage 
germ cells (eg., DDX4, DAZL), including PAX5, cannot be induced to the functional level 
(Supplementary Fig. 6a, b) 19,31,38.  Thus, PAX5 KO cells only exhibited a minor decrease in 
OCT4 expression, relative to control differentiated cells, by all three protocols (Supplementary 
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Fig. 6c). To overcome this limitation, we sorted hPGCs that were formed in vivo in mouse 
seminiferous tubules via use of GFP and cKIT and analyzed effects of PAX5 KO in vivo (Fig. 5c, 
d). Note that the niche of mouse seminiferous tubules provides a superior differentiation 
environment for hESCs to develop to more mature hPGCs that express genes essential for later 
stage germ cells, including DDX4 (Fig. 3e, f). In these in vivo derived hPGCs, there was 
significant downregulation of OCT4 expression in cells formed by PAX5 KO cells, and as also 
expected, significant upregulation of OCT4 expression in cells formed by PAX5 OE cells, 
compared to cells formed by control hESCs (Fig. 5e).  
 
To further determine whether PAX5 regulates OCT4 expression by regulating the enhancer of 
OCT4, a luciferase reporter assay was performed in 293T cells. As expected, PAX5 OE caused 
a significant increase in luciferase activity, suggesting that PAX5 could activate OCT4 
expression through its enhancer (Fig. 5f). We also identified the binding motif of PAX5 in the 
region of the OCT4 enhancer sequences (Supplementary Fig. 7a-c).  Results indicated that 
mutation of PAX5 binding motif abolished the induction effect of PAX5 protein (Supplementary 
Fig. 7d).  
 
Further analysis of ChIP-seq data indicated that PAX5 and OCT4 bind to PRDM1 enhancers 
with high intensity (Fig. 6a), suggesting that PAX5 and OCT4 might act upstream of PRDM1 to 
regulate its expression. We found an increase of PRDM1 in PAX5 OE formed hPGCs and a 
significant decrease in PAX5 KO formed hPGCs (Fig. 6c). Luciferase reporter assay in 293T 
cells showed that either PAX5 or OCT4 was able to significantly increase luciferase activity 
driven by PRDM1 enhancer (Fig. 6d). These results indicated that PAX5 and OCT4 could act on 
the PRDM1 enhancer as activators to induce PRDM1 expression, potentially during germline 
differentiation. Mutation of the PAX5 binding motif in PRDM1 enhancer region abolished the 
induction effects of PAX5 protein (Supplementary Fig. 7e-h). Since PRDM1 is a critical gene for 
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germ cell specification and it could be downstream of PAX5 and OCT4, we then overexpressed 
PRDM1 in PAX5 KO cells to test whether PRDM1 could rescue the defect of PAX5 KO cells. 
Indeed, we observed that OE of PRDM1 restores germ cell potential of PAX5 KO cells (Fig. 6e).  
Taken together, our data shed light on the epistasis of these three transcription factors during 
differentiation from hESCs to hPGCs (Fig. 6f): In pluripotent stem cells, OCT4 interacts with 
SOX2 and other cofactors, and binds to its own enhancer to activate and maintain high 
expression. In contrast, with differentiation to germ cells, PAX5 replaces OCT4, recognizes its 
own binding motif and binds to the enhancer of OCT4 to maintain a moderate expression of 
OCT4. Concurrently, PAX5 and OCT4 may bind to the enhancer of PRDM1 and activate its 
expression to initiate the germ cell program. 
 
Molecular model of PAX5-OCT4-PRDM1 network 
OCT4 is known to repress ectoderm formation from hESCs39 and during germ cell differentiation 
(Fig. 1e). In addition, PRDM1 has been shown to suppress endoderm and other somatic genes 
during gem cell specification19.  Thus, we wondered whether PAX5, together with OCT4 and 
PRDM1, might function globally during germ cell differentiation. We examined expression of 
somatic genes during in vitro differentiation (Supplementary Table 1). We detected 
downregulation of somatic genes belonging to the three primary germ layers in PAX5 OE cells 
(Fig. 7a), while in PAX5 KO cells we observed a significant upregulation of expression of 
ectodermal genes (Fig. 7b). This suggests that PAX5 could repress ectoderm and that the 
repression might be mediated through the ability of PAX5 to activate/maintain OCT4 expression. 
Moreover, consistent with previous studies on PRDM119, we observed significant upregulation 
of somatic genes in all three germ layers during differentiation of PRDM1 KO cells (Fig. 7c), 
confirming the role of this gene in suppression of differentiation of somatic lineages during 
human germ cell development. 
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Based on our data, we propose a molecular model of human germ cell development (Fig. 7d). 
Upon external signaling via factors such as the BMPs, germ cell differentiation is induced under 
both in vitro or in vivo conditions and OCT4 expression is reduced to a moderate level that is at 
least in part, maintained by partnership with PAX5. To efficiently induce and maintain germline 
programs, OCT4 represses ectodermal genes and at the same time, together with PAX5, 
activates PRDM1 to repress mesodermal and endodermal genes. In PAX5 KO cells, OCT4 
expression was so low that the expression of ectodermal genes was not suppressed effectively. 
Thus, the efficiency of induction of germ cells is very low in PAX5 KO cells. A more severe case 
is observed in PRDM1 KO cells with almost complete loss of expression of OCT4 and PRDM1, 
genes in all somatic lineages are upregulated and the germ cell programs fail to be activated. 
 
Discussion 
This work prompts a molecular model for germ cell development (Fig. 7e). In hESCs, OCT4 
partners with pluripotent master regulators, including SOX2, to form the core transcriptional 
network that governs self-renewal and pluripotency. Induced by BMP signals in vitro and in vivo, 
hESCs differentiate into early hPGCs with low efficiency. When expression of PAX5 is induced 
in hESCs, differentiation into more mature human germ cells, with significantly higher efficiency, 
results. These later stage differentiated cells closely resemble late hPGCs or gonocytes and 
express genes, such as DDX4, c-KIT and DAZL, which mark mature human germ cells. 
Conversely, loss of function of PAX5 results in lower efficiency of germ cell differentiation and 
loss of function of PRDM1 results in complete failure of germ cell specification. Thus, this study 
provides evidence that human cell fate determination, at the juncture of pluripotency and 
somatic and germ line differentiation, may be the result of a balance of forces: Co-expression of 
pluripotency genes (eg., OCT4, NANOG) simultaneously with lineage specifiers (eg., SOX17, 
PAX5, PRDM1) distinguishes hPGCs from all other human cells and from mouse PGCs. To 
maintain cell identity, hPGCs require a precise regulation/balance of pluripotency and lineage 
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specifiers to move forward from pluripotent stem cell while repressing somatic lineage 
development and activating germ cell programs. The PAX5-OCT4-PRDM1 axis that has been 
identified, along with the transcription factor genome-wide binding profiles, define the identity of 
bona fide hPGCs at stages beyond those commonly reported in vitro. The results of these 
studies may shed light on genetic requirements for human germ cell differentiation, enable more 
faithful and efficient production of human germ cells in vitro and contribute to knowledge and 
models of human germ cell pathologies. 
 
 
Figure Legends 
Figure 1. Global redistribution of OCT4 binding in PGCs compared with ESCs. (a) Cross-
section of a human fetal testis (22 weeks) with immunostaining for OCT4. Enlarged panel on the 
right represents the region enclosed within the white dashed lines of the left panel. Scale bar 
represents 50 µm. Immunostaining experiments were independently repeated a minimum of 
three times with similar results. (b) Left panel: Heatmap visualization of OCT4 ChIP-seq data, 
depicting all binding events centered on the peak region within a 5kb window around the peak. 
Right panel: Distribution and peak heights of OCT4 peaks around the transcription start site 
(TSS). Peak heights are reported in reads per million (RPM). (c) Scatterplot comparing OCT4 
binding in PGCs and ESCs. Selected genes known to be associated with pluripotency are 
highlighted in blue, and those associated with germline are highlighted in red. (d) Genome 
browser representation of ChIP-seq tracks for OCT4 in ESCs (red) and PGCs (yellow) at the 
OCT4 and PIWIL1 loci. Regions that were bound by OCT4 exclusively in ESCs or PGCs are 
highlighted by pink shaded boxes. ChIP-seq were independently repeated twice with similar 
results. (e) Venn diagram of unique and shared genes bound by OCT4 in ESCs and PGCs. 
Gene ontology analysis are shown in the right and bottom. Analysis were performed twice with 
similar results based on two independent ChIP-seq data. 
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Figure 2. Co-occurrence of OCT4 with PAX5 and PRDM1 in PGCs. (a) The position weight 
matrix of an enriched motif found in OCT4 ChIP-seq data from PGCs. The motif resembles the 
binding motifs for PRDM1 and PAX5. (b) Cross-section of a human fetal testis (22 weeks) with 
immunostaining for PAX5 (red), OCT4 (green) and DAPI stained nuclei (blue) (upper panel); 
PRDM1 (red), OCT4 (green) and DAPI stained nuclei (blue) (lower panel). Enlarged panels on 
the right represent the region enclosed within the white dashed lines of the left panel. White 
arrows indicate co-localization of PAX5 and OCT4 or PRDM1 and OCT4. Scale bars represent 
100 µm. Immunostaining experiments were independently repeated a minimum of three times 
with similar results. (c) Venn diagram of unique and shared genes bound by OCT4, PRDM1 and 
PAX5 in PGCs. The number of genes bound exclusively by each transcription factor or co-
bound by multiple transcription factors are labelled. (d) Genome browser representation of 
ChIP-seq tracks for OCT4 (yellow), PAX5 (blue) and PRDM1 (green) at the TBX3 and PIWIL1 
loci. Regions that are bound collectively by OCT4, PAX5 and PRDM1 in PGCs are highlighted 
by pink shaded boxes. ChIP-seq were independently repeated twice with similar results. (e) 
Gene ontology analysis of co-bound genes. Analysis were performed twice with similar results. 
(f) GST-pull down assay performed using OCT4 and PAX5 recombinant proteins. Pull-down 
was repeated three times with similar results. Unprocessed scans of western blot analysis are 
available in Supplementary Fig. 8. 
 
Figure 3. Overexpression PAX5 and PRDM1 enhance germ cell potential of ESCs. (a) 
Heatmap of FPKM (Fragments Per Kilobase of transcript per Million mapped reads) values for 
genes associated with germline (top) and pluripotency (bottom). _BMPs: differentiated by BMPs; 
OE: overexpression. (b) Immunostaining of differentiated cells from hESCs and PAX5 OE cells 
for DDX4 and DAPI. Scale bars represent 50 µm. Immunostaining experiments were 
independently repeated a minimum of three times with similar results. (c) Gating strategy to sort 
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mOrange+ cells from the H1 hESC line after differentiation by BMPs. (d) Schematic 
experimental design of xenotransplantion. Transplantations were performed by independently 
injecting GFP tagged human cells directly into seminiferous tubules of busulfan-treated mouse 
testes that were depleted of endogenous germ cells. Testis xenografts were analyzed by 
immunohistochemistry 2 months after injection. (e) Immunohistochemical analysis of testis 
xenografts derived from PAX5 OE, PRDM1 OE and control H1 hESCs. In all panels, dashed 
white lines indicate the outer edges of spermatogonial tubules and enlarged view are shown on 
the right. White asterisks represent GFP+/DDX4+ donor cells near the basement membrane. 
Scale bars represent 50 µm. Immunostaining experiments were independently repeated a 
minimum of three times with similar results. (f) Immunostaining of testis xenografts derived from 
PAX5 OE H1 hESCs for later stage PGC markers DAZL and DAZ1. Enlarged panel on the right 
represents the region enclosed within the white rectangles of the left panel. Scale bars 
represent 50 µm. Immunostaining experiments were independently repeated a minimum of 
three times with similar results. (g) Percentage   of   tubules   positive   for   GFP+/ DDX4+ cells 
were calculated across multiple cross-sections (relative to total number of tubules). Data are 
represented as mean ± SD of n= 4 independent replicates. P-values were calculated by two-
tailed Student’s t-test. (h) For each positive tubule, the ratio of GFP+/DDX4+ cells per tubule 
was determined. Data are represented as mean ± SD of n=5 independent replicates. P-values 
were calculated by two-tailed Student’s t-test. Source data for g and h are in Supplementary 
Table 2. 
 
Figure 4. Knock out of PAX5 or PRDM1 reduce germ cell potential of ESCs. (a) RT-qPCR 
analysis of control and PAX5 KO H1 hESCs after BMPs-induced differentiation. Abbreviations: 
_BMPs represents cells were differentiated by BMPs; KO represents knockout. Data are 
represented as mean ± SD of n=3 independent replicates. P-values were calculated by two-
tailed Student’s t-test. (b) Immunostaining of differentiated cells for DDX4 (green) and DAPI 
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stained nuclei (blue). Scale bars represent 100 µm.  Immunostaining experiments were 
independently repeated a minimum of three times with similar results. (c, f) 
Immunohistochemical analysis of testis xenografts derived from PAX5 KO (c) and PRDM1 KO (f) 
and control H1 hESCs. All images are merged from DDX4 (red), GFP (green)and DAPI-stained 
nuclei. Scale bars represent 50 µm. Immunostaining experiments were independently repeated 
a minimum of three times with similar results. (d, g) Percentage   of   tubules   positive   for   
GFP+/ DDX4+ cells were calculated across multiple cross-sections (relative to total number of 
tubules) for PAX5 KO (d) and PRDM1 KO (g) H1 hESCs. Data are represented as mean ± SD 
of n=3 independent replicates. P-values were calculated by two-tailed Student’s t-test. (e, h) For 
each positive tubule, the ratio of GFP+/DDX4+ cells per tubule was determined for PAX5 KO (e) 
and PRDM1 KO (h) H1 hESCs. Data are represented as mean ± SD of n=3 independent 
replicates. P-values were calculated by two-tailed Student’s t-test. Source data for a, d, e, g and 
h are in Supplementary Table 2. 
 
Figure 5. PAX5 acts upstream of OCT4. (a) Genome browser representation of ChIP-seq 
tracks at the OCT4 locus. Enhancer regions are highlighted by pink shaded boxes. ChIP-seq 
were independently repeated twice with similar results. (b) OCT4 expression in hESCs and in 
control and PAX5 OE cells during in vitro differentiation. Data are represented as mean ± SD of 
n=3 independent replicates. P-values were calculated by two-tailed Student’s t-test.  (c) 
Immunostaining of GFP and CKIT in mouse testis xenografts. Scale bar represents 50 µm. 
Immunostaining experiments were independently repeated a minimum of three times with 
similar results. (d) Flow cytometry analysis for GFP and CKIT of mouse testis xenografted. (e) 
RT-qPCR analysis of OCT4 expression in hPGCs formed in the mouse seminiferous tubules by 
PAX5 OE, PAX5 KO and control hESCs. Data are represented as mean ± SD of n=3 
independent replicates. P-values were calculated by two-tailed Student’s t-test. (f) Reporter 
constructs used to assay for testing OCT4 enhancer activity are shown. Genomic fragment 
17 
 
bound by PAX5 and OCT4 (in red) was inserted upstream of a luciferase gene driven by 
minimal promoter. Y-axis represents the fold enrichment of luciferase activity. Data are 
represented as mean ± SD of n=3 independent replicates. Source data for b, e and f are in 
Supplementary Table 2. 
 
Figure 6. PAX5 and OCT4 acts upstream of PRDM1 
(a) Genome browser representation of ChIP-seq tracks at the PRDM1 locus. Enhancer regions 
bound by OCT4 and PAX5 in PGCs are highlighted by pink shaded boxes. ChIP-seq were 
independently repeated twice with similar results. (b) PRDM1 expression in control, PAX5 OE 
and PAX5 KO cells during in vitro differentiation. Data are represented as mean ± SD of n=3 
independent replicates. P-values were calculated by two-tailed Student’s t-test.  (c) RT-qPCR 
analysis of PRDM1 expression in hPGCs formed in the mouse seminiferous tubules by PAX5 
OE, PAX5 KO and control hESCs. Data are represented as mean ± SD of n=3 independent 
replicates. P-values were calculated by two-tailed Student’s t-test. (d) Reporter constructs used 
to assay for testing PRDM1 enhancer activity are shown. Genomic fragment bound by PAX5 
and OCT4 (in red) was inserted upstream of a luciferase gene driven by minimal promoter. Y-
axis represents the fold enrichment of luciferase activity. Data are represented as mean ± SD of 
n=3 independent replicates. (e) RT-qPCR analysis of the expression of genes associated with 
germline. Data are represented as mean ± SD of n=3 independent replicates. P-values were 
calculated by two-tailed Student’s t-test. (f) Model for gene regulation in pluripotency and 
germline: In pluripotent stem cells, OCT4, together with other transcription factors and cofactors, 
binds to its own enhancer to activate and maintain its high expression. While differentiation 
towards germline, PAX5 replaces OCT4 and binds to the enhancer of OCT4 to maintain a 
moderate expression of OCT4; In the meantime, PAX5 and OCT4 bind to the enhancer of 
PRDM1 and activate its expression to initiate the germ cell program. TFs: transcription factors. 
Source data for b, c, d and e are in Supplementary Table 2. 
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Figure 7. Role of PAX5 and PRDM1 in hPGC specification in vitro. (a-c) RT-qPCR analysis 
of gene expression in all three germ layers in H1 hESCs, PAX5 OE cells (a) and H1 hESCs, 
PAX5 KO cells (b) and H1 hESCs, PRDM1 KO cells (c) after BMP induced differentiation. Data 
are represented as mean ± SD of n=3 independent replicates. P-values were calculated by two-
tailed Student’s t-test.  (d) Proposed molecular model for transcriptional network centered by 
PAX5, OCT4 and PRDM1 in hPGCs. Upon induced germ cell differentiation with BMPs, OCT4 
expression is reduced to moderate levels and maintained in partnership with PAX5. To 
efficiently induce germline programs, OCT4 represses ectodermal genes and at the same time, 
together with PAX5, activates PRDM1 to repress mesodermal and endodermal genes. In PAX5 
KO cells, OCT4 expression has decreased to levels so low that the expression of ectodermal 
genes has not been suppressed effectively. Thus, the efficiency of induction of germ cells is low 
in PAX5 KO cells and lower in PRDM1 KO cells: due to low expression of OCT4 and loss of 
PRDM1 function, genes in all somatic lineages are upregulated and germ cell programs fail to 
be activated. (e) Summary of data establishing roles of PAX5 and PRDM1 in hPGC 
specification in vitro and in vivo. The identity of hESCs is maintained by core transcriptional 
network centered by OCT4, SOX2 and NANOG. Induced by BMP signals in vitro or in vivo by 
xenotransplantation, hESCs start to differentiate to early hPGCs, which express early germ cell 
markers, such as OCT4, SOX17, PRDM1 and NANOS3 (Grey line with arrowhead); 
Overexpression of PAX5 is able to enhance the efficiency to early hPGCs and promote early 
hPGCs to the later stage, which express mature germ cell markers, such as DDX4, DAZL and 
DAZ1(Black line with arrowhead). Loss of PAX5 significantly reduces germ cell potential of 
hESCs (Grey dotted line with arrowhead), while loss of PRDM1 leads to failure of hPGC 
specification (red line with an end bar). Source data for a-c are in Supplementary Table 2. 
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Methods 
hESC culture and differentiation. H1 hESCs (WiCell) were maintained feeder-free on Matrigel 
(BD Biosciences)-coated plates as previously described 1-5. All cultures were grown at 37 °C 
with 5% CO2 in mTeSR1 medium (STEMCELL Technologies). To differentiate, cells were 
seeded overnight at a density of 200,000 per well in 6 well plate and medium was replaced the 
next day with differentiation media (knockout DMEM supplemented with 20% fetal bovine serum, 
1 mM l-glutamine, 0.1 mM nonessential amino acids, 0.1 mM β-mercaptoethanol and 50 ng ml-1 
recombinant human BMP4, BMP7 and BMP8b (R&D systems) as previously described5,34, 40. 
Differentiation medium was changed every other day for 7 days. 
 
Xenotransplantation assay. Human cell lines were transplanted into the testes of busulfan-
treated, immune-deficient nude mice (NCr nu/nu; Taconic) as previously described1-4,41. 
Immune-deficient nude mice were treated with a single dose of busulfan (40 mg/kg; Sigma-
Aldrich) at 5-6 weeks of age to eliminate endogenous spermatogenesis. Xenotransplantation 
was then performed 5-6 weeks after busulfan treatment by injecting 7–8 ul cell suspensions 
(1.5-3million cells/testis) containing 10% trypan blue (Invitrogen) into the seminiferous tubules of 
each recipient testes via cannulation of the efferent ducts. At 8 weeks after transplantation, 
recipient mouse testes were harvested for histology and immunohistochemical analyses. 
Procedures were evaluated and approved by the University of Pittsburgh and Montana State 
University Institutional Animal Care and Use Committee (IACUC); all procedures were compliant 
with all relevant ethical regulations regarding animal research. 
 
ChIP on human fetal testis. Second trimester human fetal testes were staged and procured 
from Advanced Bioscience Resources (ABR Inc, CA). The chromatin immunoprecipitation (ChIP) 
protocol for human fetal testis (22 weeks) was adapted from published protocols25, 26 and 
optimized as follows. Note that the protocol for tissue procurement and use was approved by 
the Institutional Review Board of Montana State University (RR-P031014-EX); all procedures 
were compliant with all relevant ethical regulations regarding human research with unidentifiable 
banked tissue. The consent was obtained from all the participants. Human fetal testis samples 
(~25mg for each ChIP) were placed in a 100mm dish on ice and finely minced using a clean 
scalpel. Minced tissue was then transferred into a 15ml conical tube. 1ml PBS with protease 
inhibitor cocktail (PIC) (Roche) was added to the tissue. To crosslink, tissue was fixed in 1.5% 
formaldehyde and rocked at room temperature for 20 min, quenched with 1 vol 250 mM glycine 
(room temperature, 5 min), and rinsed with chilled TBSE buffer (20 mM Tris-HCl, 150 mM NaCl, 
1 mM EDTA) twice. Crosslinked tissue was resuspended in PBS with PIC (1ml 0.1%SDS buffer 
for every 100ul nuclear pellet) and transferred to a Dounce homogenizer. Tissue pieces were 
then disaggregated into single cell suspension with 20-25 strokes. Cell suspension was 
transferred to a 15ml conical tube and centrifuged at 3,000 rpm in a bench top centrifuge for 5 
min at 4°C. Cells were lysed with 1% SDS Lysis Buffer (on ice, 5 min) and then centrifuged 
(2,000 rpm, 10 min). Supernatant was removed as described above and samples were 
resuspended in 0.1% SDS buffer with PIC. Samples were then sonicated with glass beads for 
12 times (30 s pulses with 30 s break interval) using the Bioruptor water bath sonicator 
(Diagenode). Chromatin extracts were then precleared with Dynal Magnetic Beads (Invitrogen) 
(4°C, 1 hr) followed by centrifugation (2,000 rpm, 30 min). Supernatant (precleared chromatin) 
was immunoprecipitated overnight with Dynal Magnetic Beads coupled with anti-OCT4 (sc-8628, 
Santa Cruz Biotechnology), anti-PAX5 (sc-1974, Santa Cruz Biotechnology), anti-PRDM1 
(C14A4, Cell Signaling Technology) antibodies. On the next day, Beads were washed by 0.1% 
SDS buffer for three times followed by a wash with TE. Chromatin was eluted by incubating 
beads in TE supplemented with 1 % SDS at 65 °C for 30 min. Afterwards, chromatin underwent 
reverse crosslinking with pronase at 42°C for 2 hrs and 67°C for 6 hrs and DNA was purified 
using phenol-chloroform extraction. ChIP DNA was subjected to 15 cycles of amplification with 
the SeqPlex DNA Amplification (Sigma). Real-time qPCR was performed (ABI PRISM 7900 
Sequence Detection System) and relative occupancy values were determined by the 
immunoprecipitation efficiency (amount of immunoprecipitated DNA relative to input). Illumina 
HiSeq 2 × 60 bp paired end reads were used for sequencing. [Isn’t this redundant with the 
statement above?] 
 
Immunofluorescence analysis for cell culture. Cells were fixed with 4% paraformaldehyde at 
room temperature for 20 minutes, permeabilized with 0.3% Triton X-100 in PBS (PBST) for 10 
minutes, and blocked for 45 minutes at room temperature in PBST containing 5% normal 
donkey serum (Jackson ImmunoResearch Laboratories). Primary antibodies were diluted at 
1:200 in blocking solution and incubated at 4 ºC overnight. The primary antibodies used in this 
study are: DDX4 (R&D #AF2030), OCT4 (Santa Cruz; sc-8628), PAX5 (Santa Cruz; sc-1974), 
PRDM1 (Cell Signaling #9115) and C-KIT (DAKO; A4502).  Appropriate Alexa Fluor 488, 594 or 
647-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories) were diluted at 
1: 300 in PBS containing 0.1% bovine serum albumin (BSA) and incubated at room temperature 
for 1 hour. One μg/mL DAPI was used for nuclear staining. Images shown are representative of 
at least three independent experiments. 
 
RNA isolation, library preparation and sequencing analysis. Total RNA was extracted using 
Acruturus PicoPure RNA Isolation Kit (Life Technologies). RNA quality was determined with 
Bioanalyzer 2100 (Agilent). Sequencing libraries were constructed by SMARTer universal low 
input RNA Kit (Clonetech) according to the manufacturer’s instructions. DNA library samples 
were submitted to the Stanford Genomics Facility and 100-base paired-end high throughput 
sequencing was performed. All sequenced libraries were mapped to the human genome using 
TopHat and Cufflink 42, 43 with default parameter setup. Differential expression was analyzed 
using StrandNGS (AvadisNGS).  
Gene expression analysis by qPCR. Total RNA for qPCR was extracted from cells using the 
RNeasy Plus Mini Kit (Qiagen) and 1ug RNA was reverse transcribed using the SuperScript® III 
First-Strand Synthesis System. Quantitative PCR was done in triplicate using the Power SYBR® 
Green PCR Master Mix (both from Life Technologies) with the data normalized to housekeeping 
genes. The primer sequences were listed in Supplementary Table 1. Data shown are 
representative of at least three independent experiments. 
 
Immunohistochemistry of recipient mouse testes. Paraformaldehyde (PFA) fixed mouse 
testes were sectioned by AML laboratories (Baltimore, MD) by paraffin embedding and 
conducting serial cross-sectioning every 5 mm. Deparafinization was conducted by two 
consecutive 10min. xylenes (Sigma-Aldrich) treatments followed by rehydration in 100%, 100%, 
90%, 80% and 70% ethanol treatments followed by a 10-minute wash in tap water. Antigen 
retrieval was conducted by boiling slides for 30 minutes in 0.01 M Sodium Citrate (pH 6.0; 
Sigma-Aldrich), cooling slides for 30 minutes, followed by a 10 minute wash in PBS. Blocking 
and permeabilization was conducted by addition of 10% normal Donkey serum (Jackson 
Immunoreearch) with 0.1% Triton X (Sigma-Aldrich) in PBS for 1 hour, followed by incubation 
with the following primary antibodies diluted in 1% blocking solution overnight at 4ºC in a 
humidified chamber. Antibodies used were: DDX4 (R&D #AF2030), GFP (Abcam; ab13970), 
OCT4 (Santa Cruz; sc-8628) and DAZL (Novus; NB100-2437). Slides were washed with PBST, 
followed by an hour incubation with fluorescently labeled secondary antibodies raised in Donkey, 
followed by additional washes with PBST. The primary antibodies were used at 1:200 and 
secondary antibodies were used at 1:300. All samples were mounted with ProLong Gold Anti-
fade mounting media containing DAPI (Life Technologies). Samples were then imaged using a 
confocal microscope (Zeiss). Quantification of GFP/DDX4 double positive staining was 
determined manually from multiple sections taken from 2–3 different depths within the testis 
(technical replicates) and from multiple clonal replicates for each transplanted cell line 
(biological replicates). 
 
Motif analysis. Motif analysis was performed using MEME-ChIP suite with default parameters. 
The novel motif for OCT4 in hPGCs were searched in TRANSFAC and JASPER databases to 
find transcription factors with similar consensus sequences 44,45. 
 
CRISPR design and PAX5-KO derivation. CRISPR guide RNAs (gRNAs) were designed 
using the online CRISPR design tool from the Massachusetts Institute of Technology 
(http://crispr.mit.edu/). Candidate gRNAs with the highest score were chosen for each genomic 
region. Oligonucleotides for these gRNAs were synthesized and cloned into plasmid pX459 
(Addgene 48139) carrying both Cas9 and gRNA expression cassettes, with one modification of 
the original plasmid in which the Cas9 promoter was replaced by the EEF1A1 promoter. The 
cutting efficiency of each gRNA construct was validated by transfecting HEK293T cells and 
sequencing the target regions in the genome. CRISPR pairs were nucleofected into H1 hESCs 
and plated as single cells. Single cells were clonally expanded and isolated for PCR to test for 
successful PAX5 deletion and sequencing. 
 
Construction of overexpression constructs by lentiviral vectors. The sequences of PAX5 
or PRDM1 were assembled with Gibson Assembly Cloning technology (NEB). Briefly, gBlocks 
(gene fragments) were synthesized by Integrated DNA Technologies (IDT), and individual 
gBlocks were assembled to one gene transcript with Gibson Assembly technology followed by 
an amplification reaction with Phusion DNA polymerase according to the manufacturer’s 
instructions. Amplified genes were ligated into the pENTR/D-TOPO vector (Life Technologies) 
for the Multisite Gateway system. Clones were transformed into One-Shot Competent 
Escherichia coli, DNA was purified and sequenced, and positive clones were used for a 
recombination reaction with the Gateway destination vector (pcDNA-DEST40). Subsequent 
transformation into One-Shot Competent E. coli, followed by DNA purification and sequencing 
for verification of correct cloning, resulted in overexpression vectors for PAX5 and PRDM1. 
Luciferase assay for enhancer activity. Enhancer sequences were generated by PCR of 
human genomic DNA discovered for gene POU5F1 and PRDM1 and then cloned into 
pGL4.28(luc2CP/minP/Hygro) (#E8461, Promega) with restricted enzymes KpnI and BmtI 
(NEB). The minimal promoter pGL4.28 is used as negative control. Luciferase activity was 
measured using dual-luciferase reporter assay system (Promega) as described in the 
manufacturer’s Manu. Gene Ontology analysis. Gene Ontology (GO) enrichment was done 
using GREAT analysis, with default parameters 46. 
 
FACS and flow cytometry. Cells were dissociated in 0.25% trypsin--EDTA (Gibco BRL) at 
37ºC for 5 min and collected by centrifugation at 200g in an Eppendorf 5702 R centrifuge. Then 
the cells were passed through the 70uM strainers (BD Biosciences) to make sure they were 
digested as single cells before they were subject to the flow cytometry. Mouse testes cells were 
dissociated with 0.25% Trypsin–EDTA for 30 minutes at 37 °C. Dissociated cells were incubated 
in 1% BSA in PBS containing primary antibodies (CKIT (A4502; DAKO)) on ice for 20 minutes. 
Cells were then analyzed for mOrange expression or CKIT/GFP using the BD FACSAriaII cell 
sorter. Analysis was performed using LSRII (Becton Dickinson) and FlowJo software (Tree Star). 
 
GST pulldown assay. The recombinant protein, OCT4 (Novus; H00005460-P01) was bound to 
glutathione-sepharose beads (Amersham) and incubated with recombinant PAX5 (Novus; 
H00005079-P01) protein overnight at 4 ºC. Beads were washed 6 times with cell lysis buffer. 
The eluents were analyzed by Western blot. The blots shown are representative of at least three 
independent experiments. 
 
Differentiation to neuronal progenitor cells from hESCs. Differentiation of hESCs to 
neuronal progenitor cells was carried out as previously described 47, 48. hESCs were dissociated 
into single cells with accutase, depleted of MEF feeders by incubating on gelatin-treated culture 
dish for 30 minutes, and then plated onto matrigel-coated dish at the density of 36000 cells/cm2 
in mTeSR1 (Stemcell Technologies) in the presence of 2 uM thiazovivin (Santa Cruz 
Biotechnology). Differentiation was started 48 hours later with KSR differentiation medium 
supplemented with different combinations of small molecules6.  Diluted fibronectin stock solution 
(with cold (4 °C) PBS to 2 µg/ml), was added to 1 ml to 1 well of 6-well plates, and plates were 
incubated at 37 °C overnight. After 20 days of differentiation, cells were replated to the poly-L-
ornithine/laminin/fibronectin plates and cultured with B27 differentiation medium. 
 
Statistics and reproducibility. No statistical methods were used to predetermine samples or 
outcomes. For the xenotransplantation studies, animals were randomly allocated into groups 
receiving various cell line injections. All statistical analyses were conducted using GraphPad 
Prism (version 5). Two tailed Student’s t-test were used when data met criteria for parametric 
analysis (normal distribution or equal variances). P-value is shown in the figures and the 
number of biological replicates for each experiment is indicated in the figure legends. 
Experiments were repeated independently at least three times. 
 
Life Sciences Reporting Summary. Further information on experimental design is available in 
the Life Sciences Reporting Summary. 
 
Data Availability. All sequencing data that support the findings of this study have been 
deposited in NCBI’s GEO under accession number GSE100639. Previously published 
sequencing data that were re-analyzed here are available under accession codes GSE60138, 
GSE39821 and GSE67259. Source data for Fig. 3g, h; 4a, d, e, g, h; 5d, e, g, h, I; 6a-c and 
Supplementary Fig. 2b; 3a, d, f; 4c-d; 6a, b; 7a, c, d, e, g, h is provided in Supplementary Table 
2. All other data supporting the findings of this study are available from the corresponding 
authors on reasonable request. 
 
 
 
 
 
 
 
 
Supplementary Figure 1 
Staining of OCT4-positive cells in human fetal testis and comparison between mixed ChIP-Seq and Standard ChIP-Seq. 
(a) Cross-section of human fetal testis (22 weeks) with immunostaining of OCT4. Scale bar represents 50 µm. (b) Immunostaining of 
OCT4 and cKIT in human fetal testis. Arrows indicate co-staining cells. Scale bar represents 50 µm. (c) Immunostaining of OCT4 and 
DDX4 proteins in human fetal testis. Arrows indicate cells that only express OCT4. Scale bar represents 50 µm. Immunostaining 
experiments in (a-c) were independently repeated a minimum of three times with similar results. (d) Schematic strategy for comparing 
mixed ChIP with conventional ChIP. (e) ChIP-qPCR for detection of peaks at OCT4 locus. ChIP-qPCR were independently repeated a 
minimum of three times with similar results. (f) Scatterplot comparing OCT4 ChIP-seq data generated in pure ESCs and 1% ESCs 
mixed with fibroblast cells. Correlation was computed using whole genome data within 10kb of transcription start site (TSS) of RefSeq 
genes. Sample size n=2 and Pearson’s correlation coefficient was used for the correlation analysis. (g) Venn diagram showing 
overlapping genes bound by OCT4 generated by ChIP-seq data in pure ESCs and 1% ESCs mixed with fibroblast cells. (h) Venn 
diagram showing overlapping genes bound by OCT4 generated by ChIP-seq data derived from two biological replicates. 
 
 
 
 
 
Supplementary Figure 2 
PAX5 and PRDM1 expression and binding in hPGCs. 
(a) Cross-section of human fetal testis (22 weeks) with immunostaining for OCT4, PAX5, PRDM1, SOX2 and IgG control. Scale bars 
represent 50 µm. Immunostaining experiments were independently repeated a minimum of three times with similar results.  (b) 
Expression level of transcription factors in hESCs and human fetal testis. Data are represented as mean ± SD of n=3 independent 
replicates. (c) Heatmap visualization of PAX5 and PRDM1 ChIP-seq data, depicting all binding events centered on the peak region 
within a 5kb window around the peak. (d) GST-pull down assay to assess protein interactions between PRDM1 and PAX5. Western 
blot images are representative of three independent experiments with similar results. Unprocessed scans of western blot analysis are 
available in Supplementary Fig. 8. Source data for b are in Supplementary Table 2. 
 
 
 
 
 
Supplementary Figure 3 
Overexpression of PAX5 and PRDM1 enhances germ cell potential of hESCs during in vitro differentiation. 
(a) RT-qPCR analysis of expression level of PAX5 in H1 ESCs, PAX5 KO and PAX5 OE cells. Data are represented as mean ± SD of 
three replicates. (b) Bright field view of PAX5 OE and PRDM1 OE cells. Scale bars represent 50 µm. Experiments were independently 
repeated a minimum of three times with similar results. (c) Immunostaining of OCT4, PAX5 and PRDM1 in PAX5 and PRDM1 
overexpression hESCs. OE represents overexpression. Scale bars represent 25 µm. Immunostaining experiments were independently 
repeated a minimum of three times with similar results. (d) RT-qPCR analysis of control, PAX5 OE and PRDM1 OE H1 hESCs before 
and after BMPs-induced differentiation. Data are represented as mean ± SD of n=3 independent replicates. (e) Genome browser 
representation of ChIP-seq tracks for PAX5 at the SYCP3 and SYCP1 loci. ChIP-seq were independently repeated twice with similar 
results. (f) RT-qPCR analysis of control and PAX5&PRDM1 double OE H1 hESCs after BMPs-induced differentiation. Data are 
represented as mean ± SD of n=3 independent replicates. Source data for a, d and f are in Supplementary Table 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 4 
Overexpression of PAX5 and PRDM1 enhances germ cell differentiation of hESCs in vivo in xenotransplantation.  
(a) Immunostaining of GFP and DAPI in untransplanted mouse testis. Scale bars represent 100 µm. Immunostaining experiments were 
independently repeated a minimum of three times with similar results. (b) Immunostaining analysis of testis xenografts derived from 
PAX5&PRDM1 double OE H1 hESCs. All images are merged from DDX4 (red), GFP (green) and DAPI-stained nuclei. Scale bars 
represent 50 µm. Immunostaining experiments were independently repeated a minimum of three times with similar results. (c) 
Percentage   of   tubules   positive   for   GFP+/ DDX4+ cells was calculated across multiple cross-sections (relative to total number of 
tubules). Data are represented as mean ± SD of n=3 independent replicates. (d) For each positive tubule, the ratio of GFP+/DDX4+ 
cells per tubule was determined. Data are represented as mean ± SD of n=3 independent replicates. Source data for c and d are in 
Supplementary Table 2. 
 
 
 
 
 
Supplementary Figure 5 
Construction of PAX5 knockout hESC line with CRISPR. 
(a) Targeting strategy of PAX5 knockout in hESC with the designated guide RNA (gRNA) and the resulting deleted sequences. (b) 
Sequences of wide type PAX5 and PAX5 KO line that show homologous recombination and deletions are shown. Grey box indicates 
CRISPR recognition site and black bars indicate deleted sequences. (c) Immunofluorescence of PAX5 on wild-type (WT) and PAX5 KO 
after BMPs-induced differentiation. Scale bars represent 50 µm. Immunostaining experiments were independently repeated a minimum 
of three times with similar results. (d) Western blot of PAX5 and ACTIN on wild type (WT) and PAX5 knockout (KO) cells. Western blot 
images are representative of three independent experiments. Unprocessed scans of Western blot analysis are available in 
Supplementary Fig. 8.  
 
 
 
 
 
Supplementary Figure 6 
Gene expression of in vitro derived hPGCs and sorting of hPGCs derived from mouse seminiferous tubules. 
(a) PAX5 expression level from previously published RNA-seq data 19, 31, 38. Data are represented as mean of three technical replicates. 
(c) Expression level of germ cell genes from RNA-seq data 19, 38. Data are represented as mean of three technical replicates.  (d) RT-
qPCR analysis of OCT4 expression in control and PAX5 KO differentiated cells in vitro. “protocol” refers to the in vitro human germ cell 
differentiation protocols developed in the specific paper 19, 38. Data are represented as mean ± SD of n=3 independent replicates. P-
value was calculated by two-tailed Student’s t-test and "ns" means not significant. Source data for a-c are in Supplementary Table 2.  
 
 
 
 
 
Supplementary Figure 7 
Identification and mutation of PAX5 binding motifs in OCT4 and PRDM1 enhancer. 
(a, e) scanning of OCT4 (a) and PRDM1 (e) enhancer regions to look for key regulatory elements (RE). OCT4 or PRDM1 enhancer 
region is shown on the top. Red bars represent putative RE. Luciferase activity is shown on the bottom. Red box indicates key RE that 
has the strongest enhancer activity. Activity is presented relative to the full-length enhancer construct and minimal promoter construct 
(MP). MP: minimal promoter; RE: regulatory element; Full-length: Full-length enhancer. Data are represented as mean ± SD of n=3 
independent replicates. (b, f) Sequence of OCT4 RE4 (b) or PRDM1 RE1 (f). Grey boxes indicate putative binding site for PAX5. PBS: 
putative binding site. (c, g) The effects of deleting the specific PBS regions in RE4 for OCT4 enhancer (c) and in RE1 for PRDM1 
enhancer (g) on luciferase reporter activity. Activity is presented relative to the wild-type construct (RE4 or RE1) and minimal promoter 
construct (MP). Red box indicates PBS whose deletion abolished the induction of luciferase activity by PAX5 OE. Data are represented 
as mean ± SD of n=3 independent replicates. (d, h) The effects of mutating PBS2 for OCT4 enhancer (d) or PBS2 for PRDM1 
enhancer (h) on luciferase reporter activity. Sequence of wide-type PBS and mutated PBS is shown on the top. Luciferase activity is 
presented relative to the wild-type construct (RE4 or RE1) and minimal promoter construct (MP). Data are represented as mean ± SD 
of n=3 independent replicates. Source data for a, c, d, e, g and h are in Supplementary Table 2.  
 
 
 
 
 
Supplementary Figure 8 
Unprocessed gel blots. 
Of note, for some immunoblotting assays membranes were cut into several pieces to incubate with different antibodies, and therefore 
the raw images of these membranes are small in size.  
 
Supplementary Table 1. Primer sequences used by category for qRT-PCR analysis. 
 
Supplementary Table 2. Statistics source data for Figure 1-7 and Supplementary Figures 1-7 
 
CATEGORY GENE FORWARD PRIMER
GAPDH ACACCATGGGGAAGGTGAAG
GUSB CATCGATGACATCACCGTCAC
HSP90AB1 CCTCACTAATGACTGGGAAGAC
ACTB CCAACCGCGAGAAGATGAC
CTNNB1 AGCTCTTACACCCACCATCC
EEF1A1 ACTGGGCAGTGAAAGTTGAC
RPLP0 GGCGACCTGGAAGTCCAA
POU5F1 GGGGACCAGTGTCCTTTCC
NANOG TGCAGAGAAGAGTGTCGCAAA
PRDM14 CACTCTGGAGACAGACCATACC
LIN28A CATGCAGAAGCGCAGATCAA
DDX4 CACGTGCAGCCGTTTAAGT
DAZL CCACAACCACGATGAATCCTA
NANOS3 CCTGACAAGGCGAAGACACA
SYCP3 ACTGCAGTCATTGAGAAACGTA
PRDM1 CCTGGTACACACGGGAGAAAA
NCAM ACATCACCTGCTACTTCCTGA
TUBB3 GAGCGGATCAGCGTCTACTA
OTX2 CAACCGCCTTACGCAGTCAA
ATCT1 GGCTCTGGGCTGGTGAA
KDR AGTGGGCTGATGACCAAGAA
ID2 AGACCCGGGCAGAACCA
AFP GCGGCCTCTTCCAGAAACTA
GATA6 GGGCTCTACAGCAAGATGAAC
GATA4 GAAAACGGAAGCCCAAGAACC
Endoderm
Housekeeping
Pluripotency
Germline
Ectoderm
Mesoderm
REVERSE PRIMER
GTGACCAGGCGCCCAATA
ACAGGTTACTGCCCTTGACA
GGAGCCCGACGAGGAATAAA
TAGCACAGCCTGGATAGCAA
TGCATGATTTGCGGGACAAA
CCCTTCCACTCATAGGGTGTA
TTGTCTGCTCCCACAATGAAAC
ACATCCACTGGCAGTACAGAA
CCATGCCACTTCCAAAAGCA
GAGTATGCTGGAGGCTGTGAA
ACTTCGTGGGGTCCTTTTCAC
GAGGGTTGATTTCTGCTTCC
GTGATGACCTGAACTGGTGAA
ACTTCCCGGCACCTCTGAA
TTCCAGCATATTCTGCACTTCA
TTGAGATTGCTGGTGCTGCTA
CTTGGACTCATCTTTCGAGAAGG
GGTTCCAGGTCCACCAGAA
GGGGTGCAGCAAGTCCATAC
AGGAGTCCTTCTGACCCATAC
ACTTCGTGGGGTCCTTTTCAC
CACACAGTGCTTTGCTGTCA
GGGGCTTTCTTTGTGTAAGCAA
GTTGGCACAGGACAATCCAA
GAAGGCTCTCACTGCCTGAA
